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ABSTRACT 
Background: N-acetylcysteine (NAC) has been suggested to prevent relapse to cocaine seeking. 
However, the psychological processes underlying its potential therapeutic benefit remain largely unknown. 
Methods: We investigated the hallmark features of addiction that were influenced by chronic NAC 
treatment in rats given extended access to cocaine: escalation, motivation, self-imposed abstinence in the 
face of punishment or propensity to relapse. For this, Sprague Dawley rats were given access either to 1 
hour (short access, ShA) or 6 hours (Long access, LgA) self-administration (SA) sessions until LgA rats 
displayed a robust escalation. Rats then received daily saline or NAC (60mg/kg, ip) treatment and were 
tested under a progressive ratio and several consecutive sessions in which lever presses were punished by 
mild electric footshocks. Results: NAC increased the sensitivity to punishment in LgA rats only, thereby 
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promoting abstinence. Following the cessation of punishment, NAC-treated LgA rats failed to recover fully 
their pre-punishment cocaine intake levels and resumed cocaine SA at a lower rate than ShA and Veh-
treated LgA rats. However, NAC altered neither the escalation of SA nor the motivation for cocaine. At the 
neurobiological level, NAC reversed cocaine-induced decreases in the glutamate transporter GLT1 
observed both in the nucleus accumbens and the dorsolateral striatum. NAC also increased the expression 
of Zif268 in the nucleus accumbens and dorsolateral striatum of LgA rats. Conclusion: Our results indicate 
that NAC contributes to the restoration of control over cocaine SA following adverse consequences, an 
effect associated with plasticity mechanisms in both the ventral and dorsolateral striatum.  
 
 
INTRODUCTION  
There is increasing evidence that cocaine addiction is associated with alterations of glutamate homeostasis 
within the corticostriatal circuitry (1), the normalization of which by the cysteine prodrug N-acetylcysteine 
(NAC), a substrate for the cysteine/glutamate antiporter, has been suggested to decrease cocaine seeking 
and promote abstinence in preclinical and clinical studies (2-6). However, the psychological and 
neurobiological mechanisms whereby NAC facilitates abstinence are not fully understood. Indeed, in a 
double-blind placebo-controlled trial (4) NAC treatment resulted neither in abstinence nor in decreases in 
cocaine intake in addicted individuals actively using drug. Instead NAC prevented the return to cocaine use 
in patients that had already achieved abstinence.  
This observation suggests that the normalization to drug naïve control levels by NAC (7) of the decreased 
glutamate levels observed in cocaine addicts (8, 9) may not be sufficient to promote abstinence and 
decrease craving (10), but may consolidate the long-lasting effect of the factors that resulted in self-initiated 
abstinence. Thus, even though preclinical studies have revealed that NAC treatment decreases cue- and 
drug-induced reinstatement of an extinguished behavioral response for cocaine or prevents the 
development of escalation of cocaine SA by restoring altered glutamate homeostasis in the nucleus 
accumbens core (AcbC) (11-14), the precise potential mechanisms whereby NAC may exert its therapeutic 
benefits, namely the maintenance of self-initiated abstinence or restored control, has not been established.  
Abstinence in humans is often self-initiated following exposure to the negative consequences of drug use in 
individuals who have lost control over their habitual cocaine intake (15). Therefore we hypothesized that 
NAC treatment may help restore control over intake following repeated exposure to punishment in rats 
displaying escalation of cocaine SA (16) and associated increased motivation for the drug (17).  
Thus, we investigated the influence of chronic NAC treatment on the escalation of cocaine intake, increased 
motivation for the drug, and the propensity to develop and maintain abstinence in the face of punishment, 
three criteria suggested to define a state of ‘addiction’ in rats (18). Rats were given either long access 
sessions (LgA) that drive escalation of cocaine SA or short access (ShA) daily sessions (19).  We then 
assessed motivation for drug in both groups using a progressive ratio (PR) reinforcement schedule (20), 
followed by punishing cocaine seeking using contingent mild footshocks (20, 21).   
Neurobiologically, in extinction-reinstatement procedures, treatment with NAC has been shown in rats to 
reverse cocaine-induced glutamatergic adaptations selectively in the AcbC (1) where pharmacogenetically-
induced astrocytic release of glutamate also decreases cue-induced reinstatement of instrumental 
responding for cocaine (22). Thus, NAC increases glial expression of the cysteine/glutamate antiporter and 
GLT1, thereby restoring extracellular levels of glutamate (11, 23) and decreasing excitatory synaptic 
transmission in the AcbC. However, studies based on acute exposure to cocaine SA followed by extinction 
may not fully capture the nature of addiction which does not result from an adaptation merely to short term 
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exposure to the drug under continuous reinforcement (18). Instead it involves the progressive development 
of compulsive drug seeking and loss of control over drug intake (24), the neurobiological substrates of 
which encompass both the ventral and the dorsolateral striatum (DLS) in humans (25, 26) and in preclinical 
models (27-30).  
Therefore, we hypothesized that the potential influence of NAC treatment over punishment-induced self-
abstinence in rats may be related to a normalization of levels of GLT1, the key molecular regulator of 
astrocytic-dependent glutamate homeostasis in both the AcbC and the DLS and that both structures may 
undergo similar plasticity mechanisms (31, 32) following self-initiated abstinence. Thus, we measured in the 
striatum of vehicle- and NAC-treated ShA and LgA rats the level of GLT1 and Zif268 proteins, the latter 
being involved both in instrumental learning–dependent plasticity mechanisms in both the ventral and 
dorsal striatum and also in long-term cocaine-induced neuronal plasticity (31-36).  
MATERIALS AND METHODS 
Animals 
Sixty male Sprague-Dawley rats (Janvier, Saint Berthevin, France.) weighing 280-290 g on arrival were 
housed in pairs under reversed light/dark cycle (lights on at 7:00 am) as described in SUPPLEMENT 1. All 
experimental procedures complied with the European and French ethical guidelines. 
Solutions 
N-acetylcysteine was prepared and administered daily as previously described (6). See 
SUPPLEMENT 1 for further details.  
Surgery 
Surgical procedures have been described previously (37) and detailed in the SUPPLEMENT 1. 
Apparatus 
The twelve operant chambers used in this study have been described previously (37). See SUPPLEMENT 
1 for more details.  
Procedures 
The details of the procedures and the timeline of the experiment are described in Fig. 1 and 
SUPPLEMENT 1. 
Western-blot 
The details of the western blot procedures are described in SUPPLEMENT 1. Each western blot was run in 
triplicate on proteins extracted from pooled bilateral punches of the AcbC or aDLS. The optical density (OD) 
of each band was normalized by the amount of cyclophiline A present in each well, to correct for variations 
in the quantity of proteins loaded, and the resulting ratio was used to assess protein concentrations. OD × 
area calculation was performed to derive an amount of protein.  
Data and statistical analysis 
Data are expressed as means ± SEM. The behavioral data were subjected to repeated-measures analyses 
of variance (ANOVAs) while western-blot data were subjected to Factorial ANOVAs (see SUPPLEMENT 1 
for more details). Upon confirmation of main effects pairwise comparisons were performed using the 
Newman Keuls post-hoc test.  
Statistical significance was claimed at  = .05. For western blot analyses, because of the heterogeneity of 
the samples, partial Eta-squared values (partial are reported as the measure of effect size to support 
the p values (38). 
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RESULTS 
LgA rats did not differ from ShA rats in their acquisition of cocaine SA but displayed a robust escalation of 
intake soon after the introduction of extended access, as expected (SUPPLEMENT 1 & Fig. S1). Following 
19 days of differential access, we measured the influence of chronic NAC treatment on the persistence of 
loss of control over cocaine intake when more effort was required to obtain the drug, the motivation for the 
drug and the propensity to refrain from, and relapse to, drug self-administration. For this, half the animals of 
each group received daily ip injections of either NAC (ShA group: n = 10, LgA group: n = 9) or vehicle (ShA 
group: n = 9, LgA group: n = 8) until the end of the experiment (Fig. 1). 
NAC neither impedes the progression of escalation of cocaine self-administration 
nor decreases the motivation for cocaine 
NAC treatment had no effect on the progression of the escalation of cocaine intake in LgA rats (Fig. 2A). 
The lack of effect of NAC treatment over the maintenance of escalated cocaine SA (fig. S2) was further 
supported by a similar escalation slope (Fig. 2B) in NAC- and Veh-treated LgA rats and thus despite a 
major difference in intake during the first hour between LgA and ShA rats. 
NAC had no effect on the propensity to engage in more effort to obtain cocaine in both ShA and LgA rats 
when more effort (i.e. training under FR5) was required to self-administer the drug (see SUPPLEMENT 1 
for further details). When rats were subsequently challenged under a PR schedule of reinforcement, under 
which the break point, defined as the final ratio a rat performed to obtain one cocaine infusion, which 
provides an index of motivation for the drug (21), NAC treatment had no effect on the motivation for cocaine 
of ShA and LgA rats despite a clear enhancement of individual propensity to lever press in the latter (Fig 
2C&D). The trend towards a decreased breakpoint in NAC-treated LgA rats did not reach statistical 
significance [F1, 15 = 2.88, p > .11], nor did the trend in the total lever presses emitted during the test (fig. 2D) 
[F1, 15 = 2.28, p > .15] and cannot be attributable to differential cocaine exposure before the session nor to a 
differential level of instrumental responding [LgA: R = -0.25, R2 = .06, p > .3 and R = -0.23, R2 = .05, p > .4, 
ShA:  R = 0.22, R2 = .05, p > 0.3 and R = 0.19, R2 = .04, p > 0.4 for total cocaine intake and total lever 
presses up to the PR session, respectively]. 
NAC increases the sensitivity to punishment and promotes self-maintained control 
over cocaine intake at relapse 
Rats progressively developed abstinence in the face of adverse consequences operationalized by three 
sessions of contingent foot-shock (20, 39) that eventually resulted in a complete cessation of cocaine intake 
in all experimental groups (Fig 3A). However, the marked differences observed in the development of 
abstinence were dependent upon both access and treatment conditions. Thus, while ShA rats, regardless 
of their treatment, stopped self-administering cocaine from the first punishment session, Veh-treated LgA 
rats displayed resistance to punishment, a behavioral feature of compulsivity (18), in that they maintained a 
higher level of cocaine intake than all the other experimental groups during the first session [p < .01].  
NAC-treated LgA rats, however, displayed a reduction in cocaine intake that was similar to that observed in 
both Veh- and NAC-ShA rats, thereby differing from Veh-LgA rats (Fig. 3A). These differences were 
dissociable from the effect of punishment on the propensity to initiate the first drug seeking response from 
one session to another which dramatically increased over the course of punished sessions regardless of 
both access and treatment conditions (Fig S4A). 
Once abstinence was established for two days, rats were returned to baseline conditions and resumed 
cocaine SA. NAC-treated LgA rats did not fully recover their pre-punishment level of cocaine intake. Thus, in 
the first post-punishment session all ShA and only Veh-treated LgA rats resumed a level of cocaine SA 
similar to that displayed before the introduction of punishment [p > 0.9]. In marked contrast, NAC-LgA rats 
had significantly reduced their cocaine intake during the two days immediately following the shock sessions 
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as compared to cocaine intake during any of the pre-punishment sessions [p < .01]. 
To better investigate the potential contribution of baseline differences between LgA and ShA rats to their 
propensity to resume cocaine self-administration after shock-induced voluntary abstinence, we computed a 
suppression score (see SUPPLEMENT 1), which revealed a pronounced rightward shift in the cumulative 
probability curve for the NAC-LgA group (Fig 3B) as compared to the ShA and Veh-LgA groups. A cluster 
analysis performed on the suppression ratio identified a group of 10 rats with a post-punishment 
suppression of cocaine intake of 77+/-10 % (Fig. 3C), containing predominantly NAC- LgA rats (n = 6) Veh- 
and NAC--LgA rats in cluster 1 and 2: p < .05]. The other clusters represented rats with a suppression of 
less than 50% that were mostly in the ShA and Veh- LgA groups thereby demonstrating that the restored 
control in NAC-LgA rats cannot be attributable to pre-punishment differences. 
This NAC-induced reduction of cocaine intake was not attributable to a difference in the latency to initiate 
the instrumental response, which was increased after the punishment sessions (Fig 3D) independently of 
treatment and access to cocaine. However, NAC-induced decrease of cocaine self-administration following 
the cessation of punishment was associated with a marked increase in the time taken by the rats to perform 
the subsequent four lever presses necessary to complete the FR5 sequence required to obtain the first 
cocaine infusion (Fig 3E). Thus, the time between the first lever press and the first infusion was significantly 
increased for NAC-LgA rats during the two sessions following punishment (p < .01) whereas no significant 
alteration of the time of FR5 completion was observed for ShA rats and Veh-LgA animals (p > .3) thereby 
suggesting that if NAC treatment did not influence the initiation of cocaine-seeking behavior in addicted rats, 
i.e., LgA rats, once this rather automatic behavioral sequence was initiated NAC did restore control over 
subsequent instrumental behavior. 
N-acetylcysteine rescues cocaine-induced-decreases in GLT1 protein levels and 
opposes the influence of cocaine exposure over Zif268 protein levels both in the 
ventral and dorsolateral striatum of LgA rats. 
The apparent restoration of control in LgA rats promoted by NAC after punishment was accompanied by a 
rescue of the access-dependent decrease in GLT1 protein levels observed progressively to develop after 
short and long term cocaine exposure not only in the AcbC but also in the DLS (Fig 4A).  
Thus, in LgA rats, in which GLT1 protein levels were significantly reduced in both the AcbC and 
DLS, NAC treatment increased GLT1 protein levels back to the level of drug-naïve vehicle controls. 
This effect of chronic NAC treatment on GLT1 protein levels across the striatum was paralleled by 
a NAC-induced increase in Zif268 protein levels in both the Acb and DLS of LgA rats as compared with 
Veh-LgA rats, a finding opposite to the observed decrease in Zif268 following NAC treatment in ShA rats 
compared with Veh-ShA rats (Fig 4B). The level of both GLT1 and Zif268 proteins in the AcbC and DLS 
were not correlated with each other, nor with cocaine intake and instrumental performance overall (total 
intake or total amount of active lever presses from day 1) or during the three punished and the five 
subsequent baseline sessions.  
DISCUSSION 
This study investigated the effects of chronic NAC treatment on rats given extended access to cocaine 
which resulted in them showing hallmark features of cocaine addiction, namely loss of control over drug 
intake, increased motivation for the drug, and maintained drug use despite adverse consequences (18). 
Chronic treatment with NAC had no measurable effect on the progression of loss of control in rats that had 
already developed escalated cocaine SA nor on the motivation for the drug measured under a progressive 
ratio schedule of reinforcement. This observation is in contrast with the previous demonstration that chronic 
NAC treatment prevents the escalation of cocaine self-administration (13). This discrepancy may stem from 
several differences between the two studies including the training history of the animals, the unit dose of 
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cocaine and the time point at which NAC treatment was initiated. Thus, in the present study rats acquired 
instrumental responding for cocaine infusions (0.8 mg/kg in 100 µl) under short access, FR1 schedule of 
reinforcement for seven days prior to being exposed to 6-hour extended access or maintained under short 
access conditions. In the previous study, rats received unit infusions of 0.5 mg/kg1 in 200µl, a unit dose and 
delivery rate both shown to greatly influence various behavioral features of cocaine self-administration, 
including motivation (40). More importantly, whereas the rats of the previous study received daily NAC 
treatment from the first of the twelve days of differential access to cocaine, i.e., from the first session of 
extended access for the LgA group, in this study rats were allowed 19 extended access sessions to develop 
a robust escalation of cocaine SA prior to receiving NAC treatment. In this study we were more interested in 
the influence of NAC on the maintenance of escalated cocaine SA in rats suggested to resemble addicted 
individuals, and not in the development of escalation, which represents a prodromal stage of addiction, and 
hence may not be a suitable target for therapeutic intervention. Thus, while NAC treatment interacts with the 
neurobiological mechanisms involved in the development of escalation of cocaine SA (13),  it does not 
influence its maintenance. This observation is in line with human studies which have revealed that NAC 
treatment does not decrease ongoing cocaine use (4). 
However, chronic NAC treatment in rats showing escalated cocaine intake dramatically reduced 
compulsivity by enabling LgA rats to withhold responding in the face of punishment, thereby achieving 
abstinence more readily. Not only did NAC-treated LgA rats display a faster decrease in cocaine SA than 
Vehicle-treated LgA rats in the face of contingent punishment, but they never fully recovered their pre-
punishment level of cocaine intake over the course of the five subsequent baseline sessions. This decrease 
in intake following punishment when the drug was again made available at no cost suggests that NAC not 
only facilitated the establishment of abstinence in the face of adverse consequences but it also promoted 
long term reduction in intake. This was paralleled by a marked increase in the latency to complete the first 
FR5 sequence leading to cocaine infusions over the five post-punishment sessions, suggesting that NAC-
treated LgA rats displayed an increased propensity to inhibit the drug-seeking instrumental sequence for a 
longer period of time post-punishment than Vehicle-treated LgA rats. 
This effect of NAC on the sensitivity to the aversive consequences of cocaine SA observed only in LgA rats 
is attributable neither to the differential access to the drug nor to a direct pharmacological effect of NAC on 
pain thresholds. Indeed, the emergence of compulsive cocaine SA has recently been shown not to be 
associated with an increase in pain threshold (41), an effect consistent with evidence that enhanced 
resistance to conditioned suppression after an extended cocaine SA history is not related to individual 
sensitivity to the aversive properties of the shock (42). Additionally, NAC diminishes the sensitivity to painful 
stimuli (43, 44); i.e., increases pain thresholds so that if the effect of NAC was dependent on its effect on 
pain mechanisms, a decrease in, rather than a potentiation of, the suppression of instrumental responding 
during punishment under NAC treatment would be expected, and this would be generalized both to ShA 
and LgA rats.  
The promotion of restored control induced by NAC in LgA rats was independent of any alteration in the 
motivation for cocaine as measured by the break point under a progressive ratio schedule of reinforcement. 
Moreover, the break point and the suppression of cocaine intake following punishment were not correlated. 
These data are in agreement with the previous demonstration that NAC reduces cue-controlled cocaine-
seeking without altering cocaine intake under a second-order schedule of reinforcement (6) suggesting that 
NAC has no effect on the reinforcing properties of cocaine despite the increased propensity to lever press 
under a progressive ratio schedule of reinforcement shown by LgA rats as compared to ShA rats.  
Thus NAC may enhance the long lasting effects of being exposed to the punishment of responding for 
cocaine on the subsequent propensity to resume drug use, but only in individuals that have lost control over 
intake. Indeed, LgA rats displayed the key behavioral characteristics of cocaine addiction: they developed a 
daily increase in their intake, so-called escalation of cocaine SA (16, 19), they displayed an apparent 
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increased motivation for cocaine as compared to ShA rats consistent with previous studies (45-47) and they 
were less sensitive to punishment than ShA rats during the first punishment session, thereby revealing the 
compulsive nature of their cocaine SA (18). 
Protracted exposure to extended access to cocaine, in conditions similar to those in the present experiment, 
triggered an almost complete resistance to probabilistic punishment in a subset of a population of rats 
tested in a seeking-taking chained schedule of reinforcement (48). The greater sensitivity to punishment in 
the present experiment may be attributed to the nature of the punishment applied (see 18, 21 for more 
details). In the procedure used here, the animal does not risk punishment to gain access to the drug as is 
the case in probabilistic punishment paradigms, but instead it must endure at least two shocks prior to every 
single infusion, making the latter punishment schedule more aversive than the former. Nevertheless, as 
previously described (48, 49), extended access to the drug facilitated the emergence of compulsive cocaine 
self-administration. In human drug addicted humans, voluntary abstinence usually arises only after 
repeated exposure to adverse consequences of drug use (50). Even though initially resisting punishment 
more than ShA rats, LgA rats developed complete abstinence after three repeated punishment sessions. 
This withholding of responses, or abstinence, in the presence of adverse consequences has been 
suggested to have face and ecological validity (18, 51).  
At the neurobiological level, cocaine exposure resulted in an access-dependent decrease in GLT1 both in 
the AcbC, as previously described (14, 52), and in the DLS. The access-dependent decrease in GLT1 was 
quantitatively similar between the AcbC and the DLS and was reversed in both striatal territories by chronic 
NAC treatment. This influence of NAC on GLT1 protein levels had already been shown to occur in the AcbC 
(2, 11, 14, 53), but not in the DLS. In this study, protein levels were quantified in rats having been given 
access to cocaine under baseline conditions after having voluntarily withheld self-administering responses 
in the face of punishment. Additionally, neither Zif268 nor GLT1 protein levels correlated with cocaine intake 
or instrumental performance, overall, or during the punished, or subsequent baseline sessions. Thus, while 
this study identifies the DLS as an additional site at which NAC regulates glutamate homeostasis and 
cellular plasticity mechanisms while contributing to restoration of control over cocaine intake in addicted 
individuals, it does not allow any inference about a causal relationship between the molecular and 
behavioral readouts. Future research is warranted to identify the cascade of cellular and molecular events, 
such as alteration of the cysteine-glutamate exchanger (54) and metabotropic glutamate receptors levels 
(55), that lead chronic NAC treatment eventually to facilitate self-initiated abstinence and subsequent 
restoration of control over intake.  
Nevertheless, the influence of cocaine exposure on the progressive decrease in GLT1 protein levels in the 
DLS and its reversal by NAC is in line with the evidence that NAC diminishes habitual control over behavior 
(56), which is dependent upon the DLS (57), and our previous demonstration that NAC dose-dependently 
decreases habitual cocaine-seeking in rats trained extensively to seek cocaine under the control of drug-
associated conditioned stimuli (6). These conditions are known to trigger a shift in the neural locus of control 
over seeking responses from the ventral to the DLS involving both glutamatergic and dopaminergic 
mechanisms (6, 27, 58). The devolution of control over cocaine seeking to the DLS is also associated with 
the development of compulsive cocaine seeking (59), which is facilitated in rats with a history of escalated 
cocaine self-administration (48).  
This ventral to dorsal striatal shift in the locus of control over compulsive drug seeking has also been shown 
in drug addicted individuals (25) who also display an increased functional connectivity between the Acb and 
DLS (26) suggested to be triggered by drug exposure (60). This view is compatible with the influence of 
NAC treatment on cocaine-induced alterations in the protein levels of the cellular plasticity marker Zif268 
(35) observed between short and extended cocaine exposure that were independent of GLT1 protein 
levels, as revealed by a lack of correlation between the two markers in both the AcbC and DLS. Thus, while 
NAC reversed the increase in Zif268 observed in the AcbC and the DLS following short access to cocaine, 
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it abolished the decrease in Zif268 observed in both striatal territories following extended access. These 
data suggest that the neurobiological locus underlying the behavioural effects of NAC in addicted rats lies 
both in the AcbC and DLS in which cellular Zif268-dependent plasticity mechanisms, involved in 
instrumental learning and the long term cellular effects of cocaine (31-36), are differentially regulated by 
short or extended access to cocaine. Thus, short access to cocaine results in similar increases in Zif268-
associated cellular plasticity mechanisms in the AcbC and DLS that may reflect drug-induced striatal 
plasticity mechanisms subserving the early effects of cocaine exposure. However, under extended access 
conditions, when rats lose control over cocaine self-administration, becoming compulsive, the striatal 
system may become resilient to cocaine-induced cellular plasticity as previously described (61), so-called 
anaplasticity (61) that could be related with the persistence of an aberrant functional coupling between the 
ventral and the dorsolateral striatum, also seen in drug-addicted humans (25), that is disrupted by NAC 
treatment. As a consequence, animals may re-establish control over their drug-seeking habits, illustrated in 
this study by the increased time NAC-LgA rats take to perform their first cocaine-seeking sequence in the 
sessions that follow their self-imposed abstinence. 
If the re-organization of glutamatergic function brought about by NAC treatment in both the ventral and 
dorsolateral striatum provides a mechanism by which control over drug intake can be regained, then other 
defining features of addiction may also be attenuated.  
ACKNOWLEDGEMENTS 
We would like to thank Pr Guylène Page for her technical support as well as Khadra Escriva and Laurence 
Turi for their precious help in the animal facility of Poitiers. 
FUNDING AND DISCLOSURE 
This research was supported by an INSERM AVENIR and an ANR12 SAMA00201 grant to DB as well as a 
Newton Trust / Cambridge University grant to DB. BJE and JM are supported by an MRC (G9536855, 
G0701500) grant to BJE and by a joint award from the MRC and Wellcome Trust in support of the 
Behavioral and Clinical Neuroscience Institute at Cambridge University. The authors declare no biomedical 
financial interests or potential conflicts of interest. 
AUTHORS CONTRIBUTION 
DB supervised the research. DB, EDucret, MP, JL, BJE and JLH designed the experiment. EDucret, MP 
and JL performed the behavioural experiments. JEM and DB performed the surgeries. MP and EDugast 
performed the western-blot experiments. EDucret, ABR, MF and MP analyzed the data. EDucret, ABR, 
JLH, JEM, BJE and DB wrote the manuscript. 
REFERENCES 
1. Kalivas PW (2009): The glutamate homeostasis hypothesis of addiction. Nature reviews 
Neuroscience. 10:561-572. 
2. Brown RM, Kupchik YM, Kalivas PW (2013): The story of glutamate in drug addiction and of N-
acetylcysteine as a potential pharmacotherapy. JAMA Psychiatry. 70:895-897. 
3. Baker D, McFarland K, Lake R, Shen H, Toda S, Kalivas P (2003): N-acetyl cysteine-induced 
blockade of cocaine-induced reinstatement. Ann N Y Acad Sci. 1003:349-351. 
Ducret et al., 2015 N-acetylcysteine, relapse and striatal plasticity 
9 
4. LaRowe S, Kalivas P, Nicholas J, Randall P, Mardikian P, Malcolm R (2013): A double-blind 
placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 22:443-
452. 
5. Murray J, Lacoste J, Belin D (2012): N-Acetylcysteine as a Treatment for Addiction. In: Belin D, 
editor. Addictions: from pathophysiology to treatment: inTech, pp 335-380. 
6. Murray J, Everitt B, Belin D (2012): N-Acetylcysteine reduces early- and late-stage cocaine seeking 
without affecting cocaine taking in rats. Addict Biol. 17:437-440. 
7. Schmaal L, Veltman D, Nederveen A, van den Brink W, Goudriaan A (2012): N-acetylcysteine 
normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance 
spectroscopy study. Neuropsychopharmacology. 37:2143-2152. 
8. Martinez D, Slifstein M, Nabulsi N, Grassetti A, Urban NB, Perez A, et al. (2014): Imaging glutamate 
homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography 
radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy. Biol Psychiatry. 75:165-171. 
9. Yang S, Salmeron BJ, Ross TJ, Xi ZX, Stein EA, Yang Y (2009): Lower glutamate levels in rostral 
anterior cingulate of chronic cocaine users - A (1)H-MRS study using TE-averaged PRESS at 3 T with an 
optimized quantification strategy. Psychiatry Res. 174:171-176. 
10. LaRowe S, Mardikian P, Malcolm R, Myrick H, Kalivas P, McFarland K, et al. (2006): Safety and 
tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 15:105-110. 
11. Kupchik Y, Moussawi K, Tang X, Wang X, Kalivas B, Kolokithas R, et al. (2012): The effect of N-
acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry. 
71:978-986. 
12. Brown R, Kupchik Y, Kalivas P (2013): The story of glutamate in drug addiction and of N-
acetylcysteine as a potential pharmacotherapy. JAMA Psychiatry. 70:895-897. 
13. Madayag A, Lobner D, Kau K, Mantsch J, Abdulhameed O, Hearing M, et al. (2007): Repeated N-
Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine. Journal of Neuroscience. 
27:13968-13976. 
14. Fischer KD, Houston AC, Rebec GV (2013): Role of the major glutamate transporter GLT1 in 
nucleus accumbens core versus shell in cue-induced cocaine-seeking behavior. J Neurosci. 33:9319-9327. 
15. Peck JA, Ranaldi R (2014): Drug abstinence: exploring animal models and behavioral treatment 
strategies. Psychopharmacology (Berl). 231:2045-2058. 
16. Dilleen R, Pelloux Y, Mar A, Molander A, Robbins T, Everitt B, et al. (2012): High anxiety is a 
predisposing endophenotype for loss of control over cocaine, but not heroin, self-administration in rats. 
Psychopharmacology (Berl).89-89. 
17. Paterson NE, Markou A (2003): Increased motivation for self-administered cocaine after escalated 
cocaine intake. Neuroreport. 14:2229-2232. 
18. Belin-Rauscent A, Fouyssac M, Bonci A, Belin D (2015): How Preclinical Models Evolved to 
Resemble the Diagnostic Criteria of Drug Addiction. Biol Psychiatry. 
19. Ahmed SH, Koob G (1998): Transition from Moderate to Excessive Drug Intake: Change in Hedonic 
Set Point. Science. 282:298-300. 
20. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ (2008): High impulsivity predicts the switch to 
compulsive cocaine-taking. Science. 320:1352-1355. 
21. Belin D, Deroche-Gamonet V (2012): Responses to novelty and vulnerability to cocaine addiction: 
contribution of a multi-symptomatic animal model. Cold Spring Harbor perspectives in medicine. 2. 
Ducret et al., 2015 N-acetylcysteine, relapse and striatal plasticity 
10 
22. Scofield MD, Boger HA, Smith RJ, Li H, Haydon PG, Kalivas PW (2015): Gq-DREADD Selectively 
Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking. Biol Psychiatry. 
23. Moussawi K, Pacchioni A, Moran M, Olive M, Gass J, Lavin A, et al. (2009): N-Acetylcysteine 
reverses cocaine-induced metaplasticity. Nat Neurosci. 12:182-189. 
24. Belin D, Belin-Rauscent A, Murray JE, Everitt BJ (2013): Addiction: failure of control over 
maladaptive incentive habits. Curr Opin Neurobiol. 23:564-572. 
25. Vollstadt-Klein S, Wichert S, Rabinstein J, Buhler M, Klein O, Ende G, et al. (2010): Initial, habitual 
and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum. 
Addiction. 105:1741-1749. 
26. Xie C, Shao Y, Ma L, Zhai T, Ye E, Fu L, et al. (2014): Imbalanced functional link between valuation 
networks in abstinent heroin-dependent subjects. Mol Psychiatry. 19:10-12. 
27. Belin D, Everitt BJ (2008): Cocaine seeking habits depend upon dopamine-dependent serial 
connectivity linking the ventral with the dorsal striatum. Neuron. 57:432-441. 
28. Hollander J, Im H, Amelio A, Kocerha J, Bali P, Lu Q, et al. (2010): Striatal microRNA controls 
cocaine intake through CREB signalling. Nature. 466:197-202. 
29. Zapata A, Minney V, Shippenberg T (2010): Shift from goal-directed to habitual cocaine seeking 
after prolonged experience in rats. J Neurosci. 30:15457-15463. 
30. Willuhn I, Burgeno L, Everitt B, Phillips P (2012): Hierarchical recruitment of phasic dopamine 
signaling in the striatum during the progression of cocaine use. Proc Natl Acad Sci U S A. 109:20703-20708. 
31. Maroteaux M, Valjent E, Longueville S, Topilko P, Girault JA, Herve D (2014): Role of the plasticity-
associated transcription factor zif268 in the early phase of instrumental learning. PLoS One. 9:e81868. 
32. Veyrac A, Besnard A, Caboche J, Davis S, Laroche S (2014): The transcription factor Zif268/Egr1, 
brain plasticity, and memory. Prog Mol Biol Transl Sci. 122:89-129. 
33. Unal CT, Beverley JA, Willuhn I, Steiner H (2009): Long-lasting dysregulation of gene expression in 
corticostriatal circuits after repeated cocaine treatment in adult rats: effects on zif 268 and homer 1a. Eur J 
Neurosci. 29:1615-1626. 
34. Knapska E, Kaczmarek L (2004): A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-
1/NGFI-A/Krox-24/TIS8/ZENK? Prog Neurobiol. 74:183-211. 
35. Valjent E, Aubier B, Corbille AG, Brami-Cherrier K, Caboche J, Topilko P, et al. (2006): Plasticity-
associated gene Krox24/Zif268 is required for long-lasting behavioral effects of cocaine. J Neurosci. 
26:4956-4960. 
36. Moratalla R, Robertson H, Graybiel A (1992): Dynamic regulation of NGFI-A (zif268, egr1) gene 
expression in the striatum. J Neurosci. 12:2609-2622. 
37. Murray JE, Dilleen R, Pelloux Y, Economidou D, Dalley JW, Belin D, et al. (2014): Increased 
impulsivity retards the transition to dorsolateral striatal dopamine control of cocaine seeking. Biol Psychiatry. 
76:15-22. 
38. Levine TR, Hullett CR (2002): Eta squared, partial eta squared, and misreporting of effect size in 
communication research. Hum Commun Res. 28:612-625. 
39. Belin D, Berson N, Balado E, Piazza PV, Deroche-Gamonet V (2011): High-novelty-preference rats 
are predisposed to compulsive cocaine self-administration. Neuropsychopharmacology. 36:569-579. 
40. Allain F, Minogianis EA, Roberts DC, Samaha AN (2015): How fast and how often: The 
pharmacokinetics of drug use are decisive in addiction. Neurosci Biobehav Rev. 
Ducret et al., 2015 N-acetylcysteine, relapse and striatal plasticity 
11 
41. Vanhille N, Ducret E, Puaud M, Ansquer S, Fouyssac M, Houeto J, et al. (2013): C.20 - Differential 
effect of environmental enrichment on the acquisition of drug use and the transition to addiction.  Biennal 
meeting of the European Behavioural Pharmacology Society. La Rochelle: Behavioural Pharmacology. 
42. Vanderschuren LJ, Everitt BJ (2004): Drug seeking becomes compulsive after prolonged cocaine 
self-administration. Science. 305:1017-1019. 
43. Chu C, Levine E, Gear RW, Bogen O, Levine JD (2011): Mitochondrial dependence of nerve growth 
factor-induced mechanical hyperalgesia. Pain. 152:1832-1837. 
44. Naik AK, Tandan SK, Dudhgaonkar SP, Jadhav SH, Kataria M, Prakash VR, et al. (2006): Role of 
oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. 
Eur J Pain. 10:573-579. 
45. Hao Y, Martin-Fardon R, Weiss F (2010): Behavioral and functional evidence of metabotropic 
glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor 
in the transition to dependence. Biol Psychiatry. 68:240-248. 
46. Specio SE, Wee S, O'Dell LE, Boutrel B, Zorrilla EP, Koob GF (2008): CRF(1) receptor antagonists 
attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berl). 196:473-482. 
47. Orio L, Edwards S, George O, Parsons LH, Koob GF (2009): A role for the endocannabinoid system 
in the increased motivation for cocaine in extended-access conditions. J Neurosci. 29:4846-4857. 
48. Pelloux Y, Everitt BJ, Dickinson A (2007): Compulsive drug seeking by rats under punishment: 
effects of drug taking history. Psychopharmacology. 194:127-137. 
49. Jonkman S, Pelloux Y, Everitt B (2012): Drug intake is sufficient, but conditioning is not necessary 
for the emergence of compulsive cocaine seeking after extended self-administration. 
Neuropsychopharmacology. 37:1612-1619. 
50. Waldorf D, Reinarman C, Murphy S (1991): Cocaine Changes: The Experience of Using and 
Quitting. Temple University Press. 
51. Economidou D, Pelloux Y, Robbins T, Dalley J, Everitt B (2009): High Impulsivity Predicts Relapse 
to Cocaine-Seeking After Punishment-Induced Abstinence. Biol Psychiatry.851-856. 
52. Fischer-Smith KD, Houston AC, Rebec GV (2012): Differential effects of cocaine access and 
withdrawal on glutamate type 1 transporter expression in rat nucleus accumbens core and shell. 
Neuroscience. 210:333-339. 
53. Scofield M, Kalivas P (2014): Astrocytic Dysfunction and Addiction: Consequences of Impaired 
Glutamate Homeostasis. Neuroscientist. 
54. Moran M, McFarland K, Melendez R, Kalivas P, Seamans J (2005): Cystine/glutamate exchange 
regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability 
to cocaine seeking. J Neurosci. 25:6389-6393. 
55. Uys J, LaLumiere R (2008): Glutamate: the new frontier in pharmacotherapy for cocaine addiction. 
CNS Neurol Disord Drug Targets. 7:482-491. 
56. Corbit LH, Chieng BC, Balleine BW (2014): Effects of repeated cocaine exposure on habit learning 
and reversal by N-acetylcysteine. Neuropsychopharmacology. 39:1893-1901. 
57. Yin HH, Knowlton BJ, Balleine BW (2004): Lesions of dorsolateral striatum preserve outcome 
expectancy but disrupt habit formation in instrumental learning. European Journal of Neuroscience. 19:181-
189. 
58. Vanderschuren L, Di Ciano P, Everitt B (2005): Involvement of the dorsal striatum in cue-controlled 
cocaine seeking. J Neurosci. 25:8665-8670. 
Ducret et al., 2015 N-acetylcysteine, relapse and striatal plasticity 
12 
59. Jonkman S, Pelloux Y, Everitt B (2012): Differential roles of the dorsolateral and midlateral striatum 
in punished cocaine seeking. J Neurosci. 32:4645-4650. 
60. Takahashi Y, Schoenbaum G, Niv Y (2008): Silencing the critics: understanding the effects of 
cocaine sensitization on dorsolateral and ventral striatum in the context of an actor/critic model. Front 
Neurosci. 2:86-99. 
61. Kasanetz F, Deroche-Gamonet V, Berson N, Balado E, Lafourcade M, Manzoni O, et al. (2010): 
Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science. 328:1709-
1712. 
 
  
Ducret et al., 2015 N-acetylcysteine, relapse and striatal plasticity 
13 
FIGURE LEGENDS 
Figure 1: Timeline of the experimental procedure  
Following iv surgery, rats were allowed one week of recovery before being exposed daily to cocaine self-
administration (SA) under a fixed ratio 1 (FR1) reinforcement schedule. After a week, differential access to 
cocaine was introduced, with half the rats maintained under a 1-hour daily access schedule (short access 
group; ShA) and the other half given a daily access to cocaine of 6 hours (long access group; LgA). 
Following 19 sessions of differential access rats were subjected chronic daily ip injections of either NAC (60 
mg/kg) or vehicle started (grey arrows) until the end of the experiment. After eight days of treatment onward, 
the response requirement was increased to a FR5 reinforcement schedule. Motivation for cocaine was 
assessed on day 38 with a progressive ratio schedule of reinforcement. After three baseline sessions rats 
were exposed to three consecutive punishment sessions during which every fourth and fifth lever press of 
each instrumental sequence (FR5) delivered a mild footshock (0.3 mA, 1s). The influence of punishment-
induced abstinence on individual propensity to relapse to escalated cocaine self-administration was 
measured over 5 sessions following the termination of punishment.  
Figure 2: Chronic NAC treatment alters neither the progression of escalation of 
cocaine intake nor the motivation for the drug 
NAC had no influence on the escalation of cocaine self-administration displayed by ShA rats [main effect of 
access: F1, 32 = 53.662, p < .001], as shown by the lack of effect on cocaine intake [main effect of treatment 
F1, 32 < 1] and access x treatment x sessions x block before/during treatment interaction: F7, 224 <1] (A) and the 
escalation slope [treatment x block before/during treatment interaction: F1, 15 <1] (B). The increased motivation in LgA, 
as revealed by a higher breakpoint under a progressive ratio schedule of reinforcement compared with ShA 
rats [main effect of access: F1, 32 = 14.85, p < .01], was not influenced by NAC [main effect of treatment: F1, 
32 = 2.94, p > .09 and treatment x access interaction: F1, 32 = 1.68, p > .2] (C).  Similarly, the level of 
instrumental responding under the PR schedule, higher in LgA rats than ShA rats [main effect of access: F1, 
32 = 14.43, p < .0001], was not influenced by NAC [main effect of treatment: F1, 32 = 2.23, p > .14 and 
treatment x access interaction: F1, 32 = 1.72, p > .19] (D). Numbers between brackets correspond to the 
number of animals in each group. Breaks represent the beginning of the treatment. **: p < 0.01 
Figure 3: NAC promotes self-maintained abstinence by increasing the sensitivity to 
the adverse consequences associated with cocaine intake 
Punishment of cocaine self-administration induced a rapid decrease in intake in all groups [main effect of 
block FR5 / punishment: F1, 32 = 350.88, p < .01]. NAC-LgA rats decreased their intake to the level of ShA rats 
faster than Veh-LgA rats [treatment x access x sessions interaction: F2, 64 = 3.93, p < .05] (A). Following the 
three punishment sessions (vertical blue bars), NAC-LgA rats recovered pre-punishment levels of cocaine 
intake at a slower rate than all the other groups [effect of block pre / post punishment: F1, 32 = 200.85, p < .01, 
treatment x punishment interaction: F1, 32 = 4.22, p < .05]. A cumulative probability curve (B) on the 
suppression score revealed a rightward shift of the curve for NAC-LgA animals (black dotted line represents 
a suppression score of 0). At the individual level, a cluster analysis (C) identified that the group of rats with 
the highest suppression score was essentially composed of NAC- LgA rats. Insert (C) represents the mean 
suppression score for each cluster. While NAC treatment did not specifically influence the increased latency 
to initiate cocaine seeking behavior following punishment [main effect of punishment (pre/post block): F1, 32 = 
13.19, p < .001, treatment: F1, 32 = 2.76, p > .1 and punishment x access x treatment interaction: F1, 32 <1] 
(D) (data are expressed in log of latency of the first active lever press), it selectively increased in NAC-LgA 
rats the time needed to complete the FR5 instrumental sequence leading to the first cocaine infusion 
[access x punishment x treatment interaction: F1, 32 = 7.70, p < .01]  (E). Breaks (D, E) represent the 
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punished sessions. **: sessions differing from Veh-LgA group,  p < 0.01 ; £: different from pre-punishment 
block, p < .05, $: block different from Veh-LgA, p  .05. Grey bands represent the average intake during the 
pre-punishment block ± SEM. 
Figure 4: N-acetylcysteine rescues cocaine-induced-decreases in GLT1 protein levels 
and increases those of Zif268 in both the ventral and dorsolateral striatum of LgA 
rats 
NAC rescued the access-dependent decrease in GLT1 protein levels following cocaine SA both in the AcbC 
and DLS [main effect of access: F2,24 = 4.73, p < .02, Partial  = .28 and treatment: F1,24=6.27, p < 
.02, partial   .2, but no structure x access or access x treatment x structure interactions: Fs < 1] 
(A). NAC also counteracted the effect of either short or extended access to cocaine SA on the 
protein levels of the plasticity marker Zif268 in the AcbC and DLS [treatment x access interaction: 
F2,24=4.26, p < .03, partial  = .26] (B). Inserts show illustrative western blots from the Naive, ShA 
and LgA groups for the protein of interest GLT1 and Zif268 as well as the house keeping gene protein 
cyclophylin obtained from from micro-punches of the AcbC or DLS of individual rats. *: different from 
vehicle-treated drug naïve controls, p < .05. 
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